Showing results (51-60 of 174) with videos related to
Sort By:
Pageof 18
Journal of Environmental Management|February 3, 2026
Planning for a more heat-adaptive mountainous village in climate change scenario: An ENVI-met approachZhao Zhou, Mengyao Gao, Ziyan Pan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2021
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation scoreGamal Shiha, Reham Soliman, Nabiel Mikhail, et al.Journal of Digestive Diseases|December 13, 2021
The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis CAhmed Al-Omary, Karen Byth, Martin Weltman, et al.Current Opinion in Gastroenterology|February 10, 2022
Metabolic dysfunction-associated fatty liver disease: a year in reviewJawaher Alharthi, Amalia Gastaldelli, Ian Homer Cua, et al.Journal of Clinical and Experimental Hepatology|March 25, 2024
Post-Liver Transplant Metabolic SyndromeAshok Choudhury, Satender P Singh, Akhil Desmukh, et al.Frontiers in Immunology|April 9, 2021
Hepatic Dendritic Cells in the Development and Progression of Metabolic SteatohepatitisNahum Méndez-Sánchez, Jacqueline Córdova-Gallardo, Beatriz Barranco-Fragoso, et al.Therapeutic Advances in Endocrinology and Metabolism|December 22, 2025
The burden of metabolic diseases in the Arab region, 1990-2021Ziyan Pan, Yasser Fouad, Faisal Abaalkhail, et al.Hepatology International|January 16, 2022
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative studyGamal Shiha, Nabiel N H Mikhail, Reham Soliman, et al.Therapeutic Advances in Endocrinology and Metabolism|December 29, 2025
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implicationsMariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Mohammed Eslam, et al.Clinical and Molecular Hepatology|November 10, 2021
MAFLD enhances clinical practice for liver disease in the Asia-Pacific regionTakumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, et al.Pageof 18